JB

Jonathan Braun

University of California: 30 patents #83 of 18,278Top 1%
CC Cedars Sinai Medical Center: 4 patents #89 of 524Top 20%
MC Memorial Sloan Kettering Cancer Center: 1 patents #402 of 761Top 55%
📍 Calabasas, CA: #71 of 4,119 inventorsTop 2%
🗺 California: #17,156 of 386,348 inventorsTop 5%
Overall (All Time): #124,429 of 4,157,543Top 3%
30
Patents All Time

Issued Patents All Time

Showing 1–25 of 30 patents

Patent #TitleCo-InventorsDate
11053310 Antibodies for the treatment of cancers Madhuri Wadehra 2021-07-06
10413577 Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life Mitsuko Lynn Yamamoto, Robert H. Schiestl, Ramune Reliene, James Borneman, Laura L. Presley 2019-09-17
10385395 Diagnostic tools for response to 6-thiopurine therapy Lin Lin 2019-08-20
10028983 Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life Mitsuko Lynn Yamamoto, Robert H. Schiestl, Ramune Reliene, James Borneman, Laura L. Presley 2018-07-24
9624304 Antibodies which bind to epithelial membrane protein 2 (EMP2) Lynn K. Gordon, Kaori Shimazaki Dadgostar, Madhuri Wadehra, Kathy A. Kelly, Anna M. Wu 2017-04-18
9464135 Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR) Lynn K. Gordon, Shawn A. Morales, David Telander 2016-10-11
9110064 Methods for diagnosis and treatment of endometrial cancer Madhuri Wadehra, Sathima Natarajan, Robert Soslow 2015-08-18
9011857 Methods of treating cancer by administering EMP2 antibodies Lynn K. Gordon, Kaori Shimazaki, Madhuri Wadehra, Kathy A. Kelly, Anna M. Wu 2015-04-21
8951740 Genotoxicity as a biomarker for inflammation Aya M. Westbrook, Robert H. Schiestl, Bo Wei 2015-02-10
8940491 Genotoxicity as a biomarker for inflammation Aya M. Westbrook, Robert H. Schiestl, Bo Wei 2015-01-27
8785602 EMP2 antibodies and methods of use thereof for causing regression of a solid tumor or symptoms thereof Lynn K. Gordon, Kaori Shimazaki Dadgostar, Madhuri Wadehra, Kathleen A. Kelly, Anna M. Wu 2014-07-22
8779104 EMP2 antibodies and methods of use thereof causing regression of a solid tumor or symptoms thereof Lynn K. Gordon, Kaori Shimazaki Dadgostar, Madhuri Wadehra, Kathleen A. Kelly, Anna M. Wu 2014-07-15
8648052 Prevention of chlamydia infection using SIRNA Lynn K. Gordon, Kaori Shimazaki, Madhuri Wadehra-Dhawan, Kathy A. Kelly 2014-02-11
8445200 Genotoxicity as a biomarker for inflammation Aya M. Westbrook, Robert H. Schiestl, Bo Wei 2013-05-21
8318906 EMP2 antibodies and their therapeutic uses Lynn K. Gordon, Kaori Shimizaki, Madhuri Wadegra-Dhawan, Kathy A. Kelly, Anna M. Wu 2012-11-27
7993867 Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen Stephan R. Targan, Christopher Sutton 2011-08-09
7993865 Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen Stephan R. Targan, Christopher Sutton 2011-08-09
7993866 Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen Stephan R. Targan, Christopher Sutton 2011-08-09
7557194 Antibody materials for an IBD-associated polypeptide Christopher Sutton 2009-07-07
7183065 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens Offer Cohavy 2007-02-27
7138237 Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen Stephan R. Targan, Christopher Sutton 2006-11-21
6821739 Methods of diagnosing and treating Crohn's disease using Pseudomonas antigens Bo Wei, Ashley Forbes 2004-11-23
6759530 IBD-associated microbial nucleic acid molecules Christopher Sutton 2004-07-06
6537768 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC panca antigens Offer Cohavy 2003-03-25
6320037 IBD-associated microbial nucleic acid molecules Christopher Sutton 2001-11-20